Holmusk Company
Holmusk is building a large Real-World Evidence (RWE) platform in behavioral health and chronic diseases which aims to expand data-driven, evidence-based care for people managing behavioral health conditions. This is made possible by bringing together specialty behavioral health data and its novel analytics platform to deliver evidence-based insight that care providers, health care payers and patients can use to make informed care and treatment decisions, and integrate care for people with both behavioral and chronic health needs. These capabilities can also aid pharma companies with R&D and commercialization of new drugs.
.jpeg)
(Reupload).png)
Technology:
Clinical Data Management Platforms, mobile health
Industry:
Analytics, Biotechnology, Clinical Data Management, Electronic Health Record (EHR), Health Care, Personal Health, Wellness, mHealth
Headquarters:
Asia-Pacific (APAC), Association of Southeast Asian Nations (ASEAN), Southeast Asia
Founded Date:
01.01.2015
Employees Number:
11-50
Funding Status:
Early Stage Venture
Acquisitions Number:
1
Investors Number:
4
Total Funding:
$31.3M
Estimated Revenue:
Less than $1M
Last Funding Date:
2020-05-18
Last Funding Type:
Series A
Register and Claim Ownership